Skip to main content

Sekundäre juvenile Osteoporose

  • Chapter
Fortbildung Osteologie

Part of the book series: Fortbildung Osteologie ((FORTOSTEO,volume 3))

  • 1479 Accesses

Zusammenfassung

Die juvenile Osteoporose tritt im Verhältnis zur Osteoporose des älteren Menschen erheblich seltener auf. Eine Erkrankung stellt aber für das betroffene Kind und dessen Familie eine erhebliche Belastung dar. Die meisten juvenilen Osteoporosen sind sekundärer Form, ausgenommen die idiopathische juvenile Osteoporose, bei der es sich um eine nichthereditäre Form der erhöhten Knochenbrüchigkeit im Kindesalter handelt, für die keine auslösende Ursache verantwortlich gemacht werden kann. Die häufigsten Ursachen sind entweder durch eine entsprechende Grunderkrankung, z. B. rheumatoide Arthritis oder iatrogen durch osteokatabole Medikamente bedingt, an erster Stelle Kortison.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bachrach LK, Ward LM (2009) Clinical review 1: Bisphosphonate use in childhood osteoporosis. J Clin Endocrinol Metab 94: 400–409

    Article  CAS  PubMed  Google Scholar 

  2. Burnham JM, Shults J, Semeao E, Foster B, Zemel BS, Stallings VA, Leonard MB (2004) Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res 19: 1961–1968

    Article  PubMed  Google Scholar 

  3. Castillo H, Samson-Fang L (2009) American Academy for Cerebral Palsy and Developmental Medicine Treatment Outcomes Committee Review Panel. Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review. Dev Med Child Neurol 51(1): 17–29

    Article  PubMed  Google Scholar 

  4. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339(14): 947–952

    Article  CAS  PubMed  Google Scholar 

  5. Hind K, Burrows M (2007) Weight-bearing exercise and bone mineral accrual in children and adolescents: a review of controlled trials. Bone 40(1): 14–27

    Article  CAS  PubMed  Google Scholar 

  6. Högler W, Briody J, Woodhead HJ, Chan A, Cowell CT (2003) Importance of lean mass in the interpretation of total body densitometry in children and adolescents. J Pediatr 143: 81–88

    Article  PubMed  Google Scholar 

  7. Loftus J, Allen R, Hesp R et al. (1991) Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: pa relatively bone-sparing effect of deflazacort. Pediatrics 88(3): 428–436

    CAS  PubMed  Google Scholar 

  8. Institute of Medicine (1997) Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. National Academic Press, Washington, DC

    Google Scholar 

  9. Thornton J, Ashcroft D, O’Neill T et al. (2008) A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management. Health Technology Assessment Vol. 12: No. 3

    Google Scholar 

  10. Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA (2004) Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. NEJM 351: 868–875

    Article  CAS  PubMed  Google Scholar 

  11. LoCascio V, Ballanti P, Milani S, Bertoldo F, LoCascio C, Zanolin EM, Bonucci E (1998) A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort. Calcif Tissue Int 62(3): 199–204

    Article  CAS  PubMed  Google Scholar 

  12. MacKelvie KJ, Petit MA, Khan KM, Beck TJ, McKay HA (2004) Bone mass and structure are enhanced following a 2-year randomized controlled trial of exercise in prepubertal boys. Bone 34(4): 755–764

    Article  PubMed  Google Scholar 

  13. Munns CF, Cowell CT (2005) Prevention and treatment of osteoporosis in chronically ill children. J Musculoskelet Neuronal Interact 5: 26–72

    Google Scholar 

  14. Semler O, Land C, Schönau E (2007) Bisphosphonate therapy for children and adolescents with primary and secondary osteoporotic diseases. Orthopäde 36(2): 146–151

    Article  CAS  PubMed  Google Scholar 

  15. Ward K, Alsop C, Caulton J, Rubin C, Adams J, Mughal Z (2004) Low magnitude mechanical loading is osteogenic in children with disabling conditions. J Bone Miner Res 19(3): 360–936

    Article  PubMed  Google Scholar 

  16. Ward L, Tricco AC, Phuong P et al. (2007) Bisphosphonate therapy for children and adolescents with secondary osteoporosis. Cochrane Database Syst Rev 17(4): CD005324

    Google Scholar 

  17. Zemel B, Bass S, Binkley T et al. (2008) Peripheral quantitative computed tomography in children and adolescents: the 2007 ISCD Pediatric Official Positions. J Clin Densitom 11: 59–74

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Niedhart, C., Maus, U. (2010). Sekundäre juvenile Osteoporose. In: Fortbildung Osteologie. Fortbildung Osteologie, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-05385-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-05385-6_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-05384-9

  • Online ISBN: 978-3-642-05385-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics